Literature DB >> 19005019

Pediatric antibody response to community-acquired Staphylococcus aureus infection is directed to Panton-Valentine leukocidin.

Eric L Brown1, M Gabriela Bowden, Rebecca S Bryson, Kristina G Hulten, Andrea S Bordt, Andrea Forbes, Sheldon L Kaplan.   

Abstract

We examined the antibody responses of pediatric patients infected with community-associated Staphylococcus aureus isolates. The data show that patients infected with Panton-Valentine leukocidin (PVL)-positive strains developed a dominant immunoglobulin G anti-PVL antibody response that correlates with markers of inflammation.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19005019      PMCID： PMC2620665          DOI： 10.1128/CVI.00360-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  22 in total

Review 1.  Staphylococcus aureus infections.

Authors:  F D Lowy
Journal:  N Engl J Med       Date:  1998-08-20       Impact factor: 91.245

2.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.

Authors:  Yves Gillet; Bertrand Issartel; Philippe Vanhems; Jean-Christophe Fournet; Gerard Lina; Michèle Bes; François Vandenesch; Yves Piémont; Nicole Brousse; Daniel Floret; Jerome Etienne
Journal:  Lancet       Date:  2002-03-02       Impact factor: 79.321

Review 3.  MSCRAMM-mediated adherence of microorganisms to host tissues.

Authors:  J M Patti; B L Allen; M J McGavin; M Höök
Journal:  Annu Rev Microbiol       Date:  1994       Impact factor: 15.500

4.  Fibronectin binding protein A of Staphylococcus aureus can mediate human T lymphocyte adhesion and coactivation.

Authors:  Y J Miyamoto; E R Wann; T Fowler; E Duffield; M Höök; B W McIntyre
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

5.  The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses.

Authors:  Lawrence Y Lee; Yuko J Miyamoto; Bradley W McIntyre; Magnus Höök; Kirk W McCrea; Damien McDevitt; Eric L Brown
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

6.  Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA.

Authors:  Rong Wang; Kevin R Braughton; Dorothee Kretschmer; Thanh-Huy L Bach; Shu Y Queck; Min Li; Adam D Kennedy; David W Dorward; Seymour J Klebanoff; Andreas Peschel; Frank R DeLeo; Michael Otto
Journal:  Nat Med       Date:  2007-11-11       Impact factor: 53.440

7.  Inhibition of complement activation by a secreted Staphylococcus aureus protein.

Authors:  Lawrence Y L Lee; Magnus Höök; David Haviland; Rick A Wetsel; Edward O Yonter; Peter Syribeys; John Vernachio; Eric L Brown
Journal:  J Infect Dis       Date:  2004-07-06       Impact factor: 5.226

8.  Cloning and characterization of a gene for a 19 kDa fibrinogen-binding protein from Staphylococcus aureus.

Authors:  M K Bodén; J I Flock
Journal:  Mol Microbiol       Date:  1994-05       Impact factor: 3.501

9.  Virulence potential of the staphylococcal adhesin CNA in experimental arthritis is determined by its affinity for collagen.

Authors:  Yi Xu; Jorge M Rivas; Eric L Brown; Xiaowen Liang; Magnus Höök
Journal:  J Infect Dis       Date:  2004-05-25       Impact factor: 5.226

10.  Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence.

Authors:  Francois Vandenesch; Timothy Naimi; Mark C Enright; Gerard Lina; Graeme R Nimmo; Helen Heffernan; Nadia Liassine; Michèle Bes; Timothy Greenland; Marie-Elisabeth Reverdy; Jerome Etienne
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883
View more
  15 in total

1.  High levels of antibody to panton-valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection.

Authors:  Christina R Hermos; Pauline Yoong; Gerald B Pier
Journal:  Clin Infect Dis       Date:  2010-10-14       Impact factor: 9.079

2.  Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.

Authors:  Eric L Brown; Yasuhiro Nishiyama; Jesse W Dunkle; Shreya Aggarwal; Stephanie Planque; Kenji Watanabe; Keri Csencsits-Smith; M Gabriela Bowden; Sheldon L Kaplan; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

Review 3.  The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

4.  Antibody responses in patients with invasive Staphylococcus aureus infections.

Authors:  G Jacobsson; P Colque-Navarro; E Gustafsson; R Andersson; R Möllby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-10       Impact factor: 3.267

5.  Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice.

Authors:  David Skurnik; Massimo Merighi; Martha Grout; Mihaela Gadjeva; Tomas Maira-Litran; Maria Ericsson; Donald A Goldmann; Susan S Huang; Rupak Datta; Jean C Lee; Gerald B Pier
Journal:  J Clin Invest       Date:  2010-08-25       Impact factor: 14.808

6.  Panton-Valentine leukocidin antibodies for the treatment of MRSA skin infections?

Authors:  Michael Otto
Journal:  Expert Rev Anti Infect Ther       Date:  2011-04       Impact factor: 5.091

7.  The Clostridium difficile quorum-sensing molecule alters the Staphylococcus aureus toxin expression profile.

Authors:  Heather T Essigmann; Charles Darkoh; Erin E McHugh; Eric L Brown
Journal:  Int J Antimicrob Agents       Date:  2017-01-19       Impact factor: 5.283

8.  A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection.

Authors:  Stephanie A Fritz; Kristin M Tiemann; Patrick G Hogan; Emma K Epplin; Marcela Rodriguez; Duha N Al-Zubeidi; Juliane Bubeck Wardenburg; David A Hunstad
Journal:  Clin Infect Dis       Date:  2013-02-27       Impact factor: 9.079

9.  Staphylococcus aureus corneal infections: effect of the Panton-Valentine leukocidin (PVL) and antibody to PVL on virulence and pathology.

Authors:  Tanweer Zaidi; Tauqeer Zaidi; Pauline Yoong; Gerald B Pier
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-01       Impact factor: 4.799

10.  Panton-valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis.

Authors:  Anne-Claude Crémieux; Oana Dumitrescu; Gerard Lina; Christian Vallee; Jean-François Côté; Martine Muffat-Joly; Thomas Lilin; Jerome Etienne; François Vandenesch; Azzam Saleh-Mghir
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.